🇺🇸 FDA
Patent

US 11040115

Method for the treatment of lysosomal storage diseases

granted A61KA61K35/28A61K38/46

Quick answer

US patent 11040115 (Method for the treatment of lysosomal storage diseases) held by Sangamo Therapeutics, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/28, A61K38/46, A61K38/465, A61K48/00